History of Pain is Associated with Hospitalization and Severe Course of COVID-19 in Children with Sickle Cell Disease

Recurrent pain causes significant morbidity for individuals with sickle cell disease (SCD) and is a marker of mortality Considering the current pandemic, it's important to understand how COVID-19 impacts individuals with SCD, a medically vulnerable population We sought to identify factors associated with more severe COVID-19 illness and hospitalization in the SCD population We established the international SECURE-SCD Registry to collect COVID-19 data in SCD patients Providers were instructed to report confirmed COVID-19 cases after the disease course was known Providers reported demographics, prior SCD complications and COVID-19 related hospitalization, severity/management strategies and death Data were without protected health information We used multivariable models to estimate the independent effects of age, sex, genotype, SCD-related and non-related comorbidities grouped by organ systems on the outcomes of severe COVID-19 and hospitalization We defined the pain variable as 0, 1-2 or >2 prior acute care visits (i e , emergency department visits, hospitalizations) for pain in the last 3 years As of October 12th, 2020, 366 COVID-19 cases in SCD patients were reported, 41 5% were children and 52 7% were female Acute pain was the most common presenting symptom of COVID-19 in SCD patients (54 6%), followed by pneumonia (27 0%) Children who had more than 2 acute care visits for pain had a more severe course of COVID-19 (OR=3 964, 95% CI (1 420, 11 065), p=0 03) and required hospitalization (OR=4 641, 95% CI (1 976, 10 900), p=0 006) Children who had 1-2 acute care visits for pain showed no significant association with COVID-19 severity (p=0 73) or hospitalization (p=0 82) In adults, there was no association between with history of frequent SCD pain and COVID outcomes Pain is the most common presenting symptom of COVID-19 in SCD patients Further, more than 2 prior acute care visits for pain is associated with severe COVID-19 course and hospitalization in children with SCD and not in adults This work was supported by Grant 2020079 from the Doris Duke Charitable Foundation